This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Caelus Pharmaceuticals B.v.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lucas Gerardus Willibrordus Sterkman: Innovator in Microbiome Health
Introduction
Lucas Gerardus Willibrordus Sterkman is a notable inventor based in Heiloo, Netherlands. He has made significant contributions to the field of microbiome health, particularly in relation to infants born via cesarean section. His innovative approach aims to address critical health issues that arise from altered intestinal microbiomes in these infants.
Latest Patents
Sterkman holds a patent titled "Fecal Matter for Preventing or Treating Intestinal Microbiome Aberrations in Cesarean Section-Born Infants." This patent reflects his commitment to improving health outcomes for vulnerable populations, particularly newborns who may face unique challenges due to their birth method. He has 1 patent to his name, showcasing his innovative spirit and dedication to research.
Career Highlights
Throughout his career, Sterkman has worked with various organizations that focus on pharmaceutical and life sciences. Notably, he has been associated with Caelus Pharmaceuticals B.V. and Caelus Lifesciences IP B.V. These experiences have allowed him to develop and refine his ideas in a collaborative environment, contributing to advancements in health science.
Collaborations
Sterkman has collaborated with esteemed colleagues, including Willem Meindert De Vos and Sanne Maria Van Der Made. These partnerships have enriched his research and have been instrumental in the development of his innovative solutions.
Conclusion
Lucas Gerardus Willibrordus Sterkman is a pioneering inventor whose work in microbiome health is making a difference in the lives of cesarean section-born infants. His dedication to innovation and collaboration highlights the importance of addressing health challenges through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile